michigan hypertension core curriculum - State of Michigan
michigan hypertension core curriculum - State of Michigan
michigan hypertension core curriculum - State of Michigan
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
to assess renal dimensions and duplex to assess renal resistive index [RRI]), and selective renal<br />
arteriography in some patients (to assess cortical blood flow and intrarenal arteriolar patterns).<br />
Individually, none <strong>of</strong> these parameters is an absolute predictor <strong>of</strong> outcome, and over-reliance on any<br />
single test may exclude patients who might benefit from revascularization. 32-34 In any given patient,<br />
certain measures may indicate greater degrees <strong>of</strong> nephropathy than others, but advanced nephropathy<br />
is characterized by proteinuria > 1 gram/24 hr, renal length < 10 cm, and RRI >0.8, compared to others<br />
with less nephropathy.<br />
Scr is the most common measure <strong>of</strong> renal function, but is limited for assessing the extent <strong>of</strong><br />
dysfunction or for distinguishing nephropathy from renal ischemia. Scr is insensitive to glomerular<br />
filtration rate (GFR) until 50-75 % <strong>of</strong> renal mass has been lost (Figure 7). <strong>State</strong>d in another way, a<br />
patient who loses 50 % <strong>of</strong> renal mass (as might occur after nephrectomy or with unilateral renal artery<br />
occlusion) should have a normal Scr; Scr > 2 mg/dL in a patient with unilateral ARAS is generally<br />
indicative <strong>of</strong> significant nephropathy. 35 Selective renal arteriography and renal biopsy can be used<br />
to assess nephropathy. Although a biopsy can reliably confirm nephropathy, it is impractical and<br />
uncommonly used. Arteriographic findings provide useful information that complements the noninvasive<br />
evaluation (Table 4, Figure 5).<br />
Clinical evaluation <strong>of</strong> renal ischemia. Several noninvasive and invasive methods have utility for<br />
estimating renal blood flow, assessing the hemodynamic significance <strong>of</strong> RAS, and identifying renal<br />
ischemia (Table 6). 36,37 Nuclear scintigraphy with Technetium-labeled pentetic acid ( 99M Tc-DTPA) is<br />
reliable for measuring fractional renal blood flow 36-39 and when used in conjunction with 125 I-Iothalamate,<br />
allows accurate measurement <strong>of</strong> total- and single kidney-GFR. In patients with unilateral RAS,<br />
hypoperfusion <strong>of</strong> the stenotic kidney is reasonable evidence for renal ischemia 36 ; patients with normal<br />
renal blood flow may have RAS, but not ischemia.<br />
The invasive evaluation <strong>of</strong> renal ischemia is based on hemodynamic assessment <strong>of</strong> RAS<br />
rather than renal artery perfusion per se (Table 6). Stenosis severity is determined by visual estimates<br />
or quantitative angiography using a single angiographic projection may be inaccurate due to plaque<br />
eccentricity and vessel foreshortening, and has poor correlation with hemodynamic significance. 40<br />
Translesional pressure gradients (TLG) can be measured with small catheters or special pressure<br />
wires, and TLG > 20 mmHg is considered hemodynamically significant. 20 Fractional flow reserve (FFR)<br />
can determine the hemodynamic significance <strong>of</strong> RAS 40,41 , and FFR < 0.80 may predict a favorable BP<br />
110 Hypertension Core Curriculum